What is the impact of a shift to remote consultations? A qualitative interview study in primary and secondary healthcare.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 40514239.
- Also identified by DOI 10.1136/bmjopen-2024-097633 and PMC identifier 12164634.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The COVID-19 pandemic prompted a significant increase in the use of remote consultations-by telephone or video-in both primary and secondary healthcare. The reported advantages of remote consulting for both patients and clinicians include greater efficiency, flexibility and convenience. However, disadvantages, such as the uncertainty created by a loss of face-to-face contact, have also been highlighted. The aim of this study was to explore, explain and interpret patients' and clinicians' perceptions and experiences of remote consultations and assist decision-making about their future use. A qualitative study based on semistructured online interviews. Primary mental healthcare or secondary care cardiology services, London, UK, February-March 2022. Primary care mental health patients (n=5), primary care clinicians (general practitioners) (n=15), secondary care cardiology patients (n=9) and secondary care cardiology clinicians (n=5). The results demonstrate that a range of factors have influenced the experiences of both clinicians and patients and indicate shifts in the norms of professional practice and clinician-patient relationships. Patients and clinicians demonstrated pragmatic acceptance of remote consultations and, looking forward, a preference for a balanced 'hybrid model' of remote and face-to-face appointments. The study also highlights a need to consolidate and build on the informal learning and adaptation to remote consulting that has already taken place.
Medical subject headings
- Remote Consultation
- Primary Health Care
- Secondary Health Care
- COVID-19